REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
27/10/2025
Voltar para busca
Dado oficial do USPTO
AIDIAN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
28/10/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 10, 37
Data de depósito
17/09/2019
Data de registro
27/10/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/10/2020
Última transação
28/10/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
16
Localização do titular
FI
Examinador
ELTON,DAVID JONATHAN
Unidade examinadora
L60
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording "AIDIAN" in stylized font.
Titulares e representantes
Titulares
Aidian Oy
Representantes
Kazuyo Morita Holland & Hart LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10Classe 37
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Diagnostic preparations for use in laboratories and for research use; chemical productsdiagnostic reagents for scientific use; diagnostic preparationsother than for medical use; diagnostic testing materialsdiagnostic test kits comprised of chemical probes and buffers for use in laboratory tests and hygiene testsother than for medical use; diagnostic reagents for laboratory use; DNA primers for laboratory use; chemicals used to extract nucleic acid from biological specimensother than for medical use; reagents in the nature of polymerase and buffers for use in the biotechnology field; chemicals for use as DNA extraction controlsother than for medical use; chemicals for use as RNA extraction controlsother than for medical use; negative controlsnegative control solutions for use in laboratory tests; calibrating solutionscalibrating fluids for blood analyzers
Classe 5
Chemical preparations for medical usefor detecting infectious diseasesdisordersproteinsdiabetes managementhormoneshygienevirusesbacteriaorgans and blood; diagnostic preparations for medical use; diagnostic testing materials for medical usemedical diagnostic reagents and assays for testing body fluids; diagnostic substances for medical purposes; pharmaceutical preparations for the treatment of bacterial infections; medical diagnostic reagents; medical diagnostic test strips for blood analysisurine analysissaliva analysisfaeces analysis; diagnostic reagents for medical purposes; medical diagnostic reagents; diagnostic preparations for medical purposes; diagnostic kits comprising diagnostic reagentsmonoclonal antibodies and buffers for medical use; reagents for medical purposes; chemical reagents for medical purposes; cartridges containing reagents for use in calibrating portable blood analyzers
Classe 10
Diagnostic apparatus for medical and veterinary purposes for testing infectious diseasesdisordersdiabetes managementproteinshormoneshygienevirusesbacteriaorgans and blood; medical apparatus and instruments for diagnostic useapparatus and instruments for medical diagnostic testing in the fields of point-of-carenear-patient-testinginfectious diseasessepsishematologycardiovascular diseasesdiabetes managementcancerbone and tissue disorderstissue-based diagnostic testingcytology and cell-based testing; electronic apparatus for medical diagnosiselectromagnetic medical diagnostic imaging apparatus; medical apparatus and instruments for testing bodily fluids; bloodtissuemucosa and faeces testing apparatusnamely blood and mucosatissuefaeces sampling tubes; medical devices for use in treating or diagnosing infectious diseasessepsishematologycardiovascular diseasesdiabetes managementcancerbone and tissue disorders; medical diagnostic instruments for in vitro diagnostic testing and/or analysis; laboratory equipment for use in the field of medical diagnostics; medical DNA sequencers for medical diagnostic purposes; medical diagnostic devicea system comprising a hand-held meterlancetstest strips and control solution for infectious diseasessepsishematologycardiovascular diseasesdiabetes managementcancerbone and tissue disorders; replacement parts and fittings for all the aforesaid goods
Classe 37
Installationrepair and maintenance of medical apparatus and instruments; installationrepair and maintenance of medical diagnostic apparatus and instruments; providing information and consultation relating to the installationrepair and maintenance of medical apparatus and instruments; providing information and consultation relating to the installationrepair and maintenance of medical diagnostic apparatus and instruments
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/03/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/02/2021
FIMP
FINAL DISPOSITION PROCESSED
05/02/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
27/01/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
27/10/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/08/2020
PUBO
PUBLISHED FOR OPPOSITION
11/08/2020
GPNX
NOTIFICATION PROCESSED BY IB
07/08/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
22/07/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
22/07/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/07/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/07/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/06/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/06/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
29/06/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
22/06/2020
GNFR
FINAL REFUSAL E-MAILED
22/06/2020
CNFR
FINAL REFUSAL WRITTEN
22/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/05/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/05/2020
ALIE
ASSIGNED TO LIE
28/05/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/05/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
01/05/2020
RFNT
REFUSAL PROCESSED BY IB
14/12/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
22/11/2019
RFRR
REFUSAL PROCESSED BY MPU
22/11/2019
MAFR
APPLICATION FILING RECEIPT MAILED
02/11/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/11/2019
CNRT
NON-FINAL ACTION WRITTEN
31/10/2019
DOCK
ASSIGNED TO EXAMINER
29/10/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/10/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
24/10/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AIDIAN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.